Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for ß-Thalassemia Patients.
Biomedicines
; 10(1)2022 Jan 17.
Article
in En
| MEDLINE
| ID: mdl-35052868
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Biomedicines
Year:
2022
Document type:
Article
Affiliation country:
Malaysia
Country of publication:
Switzerland